•
Guangzhou Boji Medical Biotechnological Co., Ltd, a Clinical Research Organization (CRO) based in China and listed on the Shenzhen Stock Exchange (SHE: 300404), has entered into a strategic partnership with its wholly-owned Traditional Chinese Medicine (TCM) subsidiary and CapitalBio Pharma, a domestic firm, to collaborate on the research and development…